Security record · archived quarter
BEAM
Beam Therapeutics Inc. · Healthcare · Biotechnology
11Tracked holders
—Δ holders
12.82MShares held
$300.27MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | +9 | 71.47M | $2.45B | +12 | −3 |
| Q1 2026 | 92 | +3 | 70.17M | $1.67B | +9 | −6 |
| Q4 2025 | 89 | +3 | 73.41M | $2.04B | +4 | −1 |
| Q3 2025 | 16 | -1 | 52.77M | $1.28B | +1 | −2 |
| Q2 2025 | 14 | 0 | 51.27M | $872.17M | +1 | −1 |
| Q1 2025 | 11 | -2 | 20.67M | $403.69M | — | −2 |
| Q4 2024 | 13 | +2 | 16.59M | $411.47M | +3 | −1 |
| Q3 2024 | 10 | -1 | 11.89M | $291.41M | — | −1 |
| Q2 2024 | 11 | — | 12.82M | $300.27M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 7.63M | — | $178.68M | 1.6% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.73M | — | $40.53M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 1.73M | — | $40.53M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.39M | — | $32.66M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.39M | — | $32.66M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 769.15K | — | $18.02M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 769.15K | — | $18.02M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 623.64K | — | $14.61M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Baillie Gifford ✦ | 623.64K | — | $14.61M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Baillie Gifford ✦ | 623.64K | — | $14.61M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Baillie Gifford ✦ | 623.64K | — | $14.61M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Norges Bank ✦ (passive) | 410.80K | — | $9.63M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 120.77K | — | $2.83M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 80.84K | — | $1.89M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Wellington Management ✦ | 43.11K | — | $1.01M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 43.11K | — | $1.01M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 43.11K | — | $1.01M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 43.11K | — | $1.01M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 9.01K | — | $211,128 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 8.72K | — | $204,333 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 248 holders, 107.79M shares, $2.49B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API